Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jacobson Pharma Corporation Limited ( (HK:2633) ) just unveiled an update.
Jacobson Pharma Corporation Limited announced an interim dividend of HKD 0.0425 per share for the six months ending September 30, 2025, with a payment date set for December 18, 2025. This announcement reflects the company’s stable financial performance and commitment to providing shareholder value, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:2633) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Jacobson Pharma Corporation Limited stock, see the HK:2633 Stock Forecast page.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of generic drugs and proprietary medicines. The company primarily serves the Hong Kong market, with a strategic emphasis on expanding its product portfolio and market presence.
Average Trading Volume: 540,971
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.81B
See more data about 2633 stock on TipRanks’ Stock Analysis page.